Professional Summary
Professional Overview
David Dreyer is an accomplished Chief Financial Officer with over 30 years of diverse experience in the pharmaceutical, medical technology, and healthcare industries. He is known for his strategic financial leadership, operational expertise, and successful track record of driving growth and profitability for organizations.
Current Role
As the Chief Financial Officer at AmeriPharma Specialty Care, David is responsible for overseeing all financial operations, including financial planning, analysis, reporting, and compliance. He provides strategic guidance to the executive team, ensuring the company's financial health and positioning it for long-term success in the specialty pharmaceutical market.
Career Progression
Prior to his current role, David served as the Chief Financial Officer at Savage Enterprises LTD EU, Prolacta Bioscience, BIOLASE, Stryker SurgiCount (formerly Patient Safety Technologies), Alphastaff, AMN Healthcare, and Teva Pharmaceuticals. He has a proven history of driving operational efficiency, implementing cost-saving initiatives, and leading successful mergers and acquisitions. David's extensive experience and deep industry knowledge have made him a trusted financial leader in the healthcare and life sciences sectors.
Academic Background
David holds a Bachelor's degree in Accounting from the University of California, Berkeley. He is a Certified Public Accountant (CPA) and has completed executive leadership programs at prestigious institutions, including the Harvard Business School.
Areas of Expertise
- Financial planning, analysis, and reporting
- Mergers, acquisitions, and integrations
- Cost optimization and operational efficiency
- Regulatory compliance and risk management
- Strategic decision-making and business transformation
- Leadership and team development
Professional Impact
Throughout his career, David has made significant contributions to the organizations he has served. He has successfully navigated complex financial challenges, implemented innovative strategies, and delivered strong financial performance. David's expertise and leadership have been instrumental in driving growth, improving profitability, and enhancing the overall competitiveness of the companies he has worked with.
Conclusion
With his extensive financial acumen, deep industry knowledge, and proven track record of success, David Dreyer is poised to continue making a meaningful impact as the Chief Financial Officer at AmeriPharma Specialty Care. His commitment to strategic financial management and operational excellence positions him as a valuable asset to the organization and its stakeholders.
